<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09214</article-id><article-id pub-id-type="doi">10.7554/eLife.09214</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-35688"><name><surname>Grosso</surname><given-names>Ana Rita</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35689"><name><surname>Leite</surname><given-names>Ana Paula</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11251"><name><surname>Carvalho</surname><given-names>Sílvia</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35690"><name><surname>Matos</surname><given-names>Mafalda Ramos</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11254"><name><surname>Martins</surname><given-names>Filipa Batalha</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45735"><name><surname>Vítor</surname><given-names>Alexandra Coitos</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11256"><name><surname>Desterro</surname><given-names>Joana MP</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35691"><name><surname>Carmo-Fonseca</surname><given-names>Maria</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-11171"><name><surname>de Almeida</surname><given-names>Sérgio Fernandes</given-names></name><aff><institution content-type="dept">Instituto de Medicina Molecular</institution>, <institution>Faculdade de Medicina da Universidade de Lisboa</institution>, <addr-line><named-content content-type="city">Lisboa</named-content></addr-line>, <country>Portugal</country><email>sergioalmeida@fm.ul.pt</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1069"><name><surname>Dang</surname><given-names>Chi Van</given-names></name><role>Reviewing editor</role><aff><institution>University of Pennsylvania</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>11</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e09214</elocation-id><supplementary-material><ext-link xlink:href="elife-09214-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>03</day><month>06</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Grosso et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Grosso et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Aberrant expression of cancer genes and non-canonical RNA species is a hallmark of cancer. However, the mechanisms driving such atypical gene expression programs are incompletely understood. Here, our transcriptional profiling of a cohort of 50 primary clear cell renal cell carcinoma (ccRCC) samples from The Cancer Genome Atlas (TCGA) reveals that transcription read-through beyond the termination site is a source of transcriptome diversity in cancer cells. Amongst the genes most frequently mutated in ccRCC, we identified <italic>SETD2</italic> inactivation as a potent enhancer of transcription read-through. We further show that invasion of neighbouring genes and generation of RNA chimeras are functional outcomes of transcription read-through. We identified the <italic>BCL2</italic> oncogene as one of such invaded genes and detected a novel chimera, the <italic>CTSC-RAB38</italic>, in 20% of ccRCC samples. Collectively, our data highlight a novel link between transcription read-through and aberrant expression of oncogenes and chimeric transcripts that is prevalent in cancer.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>